Nek4 Activators encompass a subset of compounds that influence the cellular signaling pathways to which Nek4 is integral, ultimately leading to its enhanced activity. Nek4, a serine/threonine-protein kinase, plays a pivotal role in various cellular processes, including the regulation of cell cycle progression and response to DNA damage. Activators of Nek4 may work by affecting proteins upstream in the signaling cascade or by altering the cellular environment to favor the kinase's activation state. For instance, compounds that increase the levels of cellular ATP can indirectly enhance Nek4 activity, as ATP is a substrate for Nek4's kinase activity. Similarly, molecules that stabilize microtubule dynamics may promote Nek4 activation, given that Nek4 is known to associate with microtubules and may be regulated by their polymerization status. Furthermore, activators may include small molecules that bind directly to Nek4, leading to a conformational shift that promotes kinase activity, although such direct activators are less common and not well-characterized for Nek4 specifically.
The modulation of Nek4 activity by these activators does not necessarily correlate with changes in protein expression levels, but rather with the enhancement of the protein's intrinsic kinase activity. Chemicals that alter the phosphorylation state of proteins interacting with Nek4 can also serve as activators. By inhibiting phosphatases that target Nek4 or its substrates, these activators preserve the phosphorylation-dependent signaling events that facilitate Nek4's role in cellular functions. Additionally, compounds that modulate cellular stress responses can indirectly activate Nek4, since stress conditions such as oxidative stress have been found to influence the kinase's activity. By increasing the generation of reactive oxygen species, certain chemicals can mimic stress conditions and thereby potentiate Nek4's role in managing cellular damage responses. Collectively, Nek4 Activators enhance the functional performance of Nek4, thereby influencing the kinase's role in maintaining cellular homeostasis and integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can lead to the activation of PKA. PKA can then phosphorylate specific substrates including those that could be part of signaling cascades involving Nek4, indirectly leading to its activation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
This lipid signaling molecule activates sphingosine-1-phosphate receptors, which can trigger pathways that lead to cytoskeletal rearrangements, potentially affecting signaling pathways that Nek4 is part of, thus enhancing Nek4 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Although a broad-spectrum kinase inhibitor, staurosporine can selectively enhance Nek4 activity by inhibiting kinases that negatively regulate pathways involving Nek4. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in numerous signaling pathways. PKC activation could lead to downstream effects that enhance the activity of Nek4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which could lead to alterations in the PI3K/AKT pathway, indirectly affecting pathways that Nek4 is involved in, thus enhancing its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor, which operates similarly to LY294002, potentially affecting Nek4 activity through changes in related signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which could lead to an increase in alternative signaling routes that may activate Nek4 indirectly. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore, raising intracellular calcium levels and potentially activating calcium-dependent pathways that could intersect with pathways involving Nek4. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a known kinase inhibitor that may affect various signaling pathways, possibly leading to enhanced Nek4 activity through indirect mechanisms. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases, which may reduce competitive signaling and allow for the enhanced activity of pathways involving Nek4. | ||||||